FIELD: chemistry.
SUBSTANCE: invention is a humanised form of mouse anti c-met antibody. The disclosed antibody enables different degrees of impairment of the HGF/c-met signalling pathway.
EFFECT: improved method.
29 cl, 17 dwg, 2 tbl, 1 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD OF TUMOUR TREATMENT IN SUBJECT | 2006 |
|
RU2404193C2 |
| ANTI c-Met RECEPTOR PROTEIN ANTIBODIES | 2011 |
|
RU2608644C2 |
| HUMANISED ANTI-BETA 7 ANTAGONISTIC ANTIBODIES AND USE THEREOF | 2005 |
|
RU2453558C2 |
| METHODS AND COMPOSITION FOR SECRETION OF HETEROLOGOUS POLYPEPTIDES | 2010 |
|
RU2585488C2 |
| THEOPHYLLINE ANTIBODIES AND METHODS FOR THEIR APPLICATION | 2013 |
|
RU2630664C2 |
| DLL4 ANTIBODIES AND METHODS OF APPLICATION THEREOF | 2007 |
|
RU2415869C2 |
| ANTI-TAT226 ANTIBODIES AND IMMUNOCONJUGATES | 2007 |
|
RU2448980C2 |
| ANTI-CD79B ANTIBODIES, IMMUNOCONJUGATES AND METHODS FOR THEIR USE | 2019 |
|
RU2791984C2 |
| HUMANISED ANTI-FACTOR D ANTIBODIES AND APPLICATIONS THEREOF | 2012 |
|
RU2678802C2 |
| ANTI-CD79b ANTIBODIES AND IMMUNOCONJUGATES AND METHODS FOR USING THEM | 2008 |
|
RU2511410C2 |
